0

531210

COLINZ

img img img img
No Data Available

COLINZ LABORATORIES LTD. Share Price Update

As of the latest trading session, COLINZ LABORATORIES LTD. is trading at ₹53.47, up by ₹2.54 or 4.98% from its previous close. The stock has moved between ₹53.47 and ₹53.47 today. Over the past year, the stock has delivered a return of -14.77%. In the last month, it has returned 11.76%.

Investment Returns

Over 1 Month 11.76% Over 3 Months 18.13% Over 6 Months 34.34% Over 1 Year -14.77%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

COLINZ LABORATORIES LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 6.70
  • P/E Ratio (TTM) 13.11
  • Beta 0.19
  • Book Value / share 69.70
  • Return on equity 5.43%
  • EPS (TTM) 4.08
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.17
info icon alternate text

COLINZ LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 1.75
Operating Expense 1.71
Net Profit 0.17
Net Profit Margin (%) 9.71
Earnings Per Share (EPS) 0.68
EBITDA 0.27
Effective Tax Rate (%) 18.18
Particulars DEC 2025 (Values in Cr)
Revenue 1.43
Operating Expense 1.38
Net Profit 0.08
Net Profit Margin (%) 5.59
Earnings Per Share (EPS) 0.33
EBITDA 0.18
Effective Tax Rate (%) 30.76
Particulars SEP 2025 (Values in Cr)
Revenue 1.39
Operating Expense 1.36
Net Profit 0.14
Net Profit Margin (%) 10.07
Earnings Per Share (EPS) 0.56
EBITDA 0.24
Effective Tax Rate (%) 26.31
Particulars JUN 2025 (Values in Cr)
Revenue 1.57
Operating Expense 1.48
Net Profit 0.12
Net Profit Margin (%) 7.64
Earnings Per Share (EPS) 0.47
EBITDA 0.21
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 1.45
Operating Expense 1.41
Net Profit 0.15
Net Profit Margin (%) 10.34
Earnings Per Share (EPS) 0.60
EBITDA 0.16
Effective Tax Rate (%) -25.00
Particulars MAR 2026 (Values in Cr)
Revenue 6.14
Operating Expense 5.93
Net Profit 0.51
Net Profit Margin (%) 8.30
Earnings Per Share (EPS) 2.04
EBITDA 0.90
Effective Tax Rate (%) 24.63
Particulars MAR 2025 (Values in Cr)
Revenue 6.53
Operating Expense 6.20
Net Profit 0.50
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 1.97
EBITDA 0.79
Effective Tax Rate (%) 19.35
Particulars MAR 2024 (Values in Cr)
Revenue 7.03
Operating Expense 6.66
Net Profit 0.49
Net Profit Margin (%) 6.97
Earnings Per Share (EPS) 1.93
EBITDA 0.82
Effective Tax Rate (%) 24.61
Particulars MAR 2023 (Values in Cr)
Revenue 7.15
Operating Expense 6.72
Net Profit 0.46
Net Profit Margin (%) 6.43
Earnings Per Share (EPS) 1.82
EBITDA 0.78
Effective Tax Rate (%) 23.33
Particulars MAR 2022 (Values in Cr)
Revenue 6.97
Operating Expense 6.67
Net Profit 0.34
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 0.74
EBITDA 0.76
Effective Tax Rate (%) 29.16
Particulars MAR 2025 (Values in Cr)
Book Value / Share 37.61
ROE % 5.43
ROCE % 6.72
Total Debt to Total Equity 0.07
EBITDA Margin 12.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 35.52
ROE % 5.73
ROCE % 7.70
Total Debt to Total Equity 0.05
EBITDA Margin 11.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.31
ROE % 5.81
ROCE % 7.82
Total Debt to Total Equity 0.05
EBITDA Margin 10.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 21.69
ROE % 4.54
ROCE % 6.78
Total Debt to Total Equity 0.10
EBITDA Margin 10.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.57
ROE % 2.97
ROCE % 4.36
Total Debt to Total Equity 0.10
EBITDA Margin 8.60
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.55
Total Assets 11.81
Total Liabilities 11.81
Total Equity 9.47
Share Outstanding 0
Price to Book Ratio 1.93
Return on Assets (%) 4.20
Return on Capital (%) 4.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.00
Total Assets 11.35
Total Liabilities 11.35
Total Equity 8.94
Share Outstanding 0
Price to Book Ratio 1.06
Return on Assets (%) 4.28
Return on Capital (%) 5.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.72
Total Assets 10.23
Total Liabilities 10.23
Total Equity 8.13
Share Outstanding 0
Price to Book Ratio 1.08
Return on Assets (%) 4.47
Return on Capital (%) 5.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.20
Total Assets 9.93
Total Liabilities 9.93
Total Equity 7.68
Share Outstanding 0
Price to Book Ratio 1.09
Return on Assets (%) 3.41
Return on Capital (%) 4.15
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.68
Total Assets 10.10
Total Liabilities 10.10
Total Equity 7.29
Share Outstanding 0
Price to Book Ratio 0.37
Return on Assets (%) 2.05
Return on Capital (%) 2.51
Particulars MAR 2025 (Values in Cr)
Net Income 0.61
Cash from Operations -1.24
Cash from Investing -0.23
Cash from Financing 0.23
Net change in Cash -1.45
Free Cash Flow -0.98
Particulars MAR 2024 (Values in Cr)
Net Income 0.65
Cash from Operations 1.21
Cash from Investing 0.00
Cash from Financing 0.22
Net change in Cash 1.27
Free Cash Flow 1.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.59
Cash from Operations 0.56
Cash from Investing 0.00
Cash from Financing 0.11
Net change in Cash 0.52
Free Cash Flow 0.56
Particulars MAR 2022 (Values in Cr)
Net Income 0.48
Cash from Operations 0.61
Cash from Investing -0.03
Cash from Financing 0.09
Net change in Cash 0.52
Free Cash Flow 0.65
Particulars MAR 2021 (Values in Cr)
Net Income 0.24
Cash from Operations 2.23
Cash from Investing -0.15
Cash from Financing 0.08
Net change in Cash 2.08
Free Cash Flow 2.39
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 14.75 1.72 273.50 23.12 40.00
BLISS GVS PHARMA LTD. 424.80 34.37 3.76 4493.92 118.35 437.40
CIPLA LTD. 1398.50 27.69 3.28 112970.91 1165.55 1672.20
FERMENTA BIOTECH LTD. 295.20 13.02 2.13 868.80 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2208.70 36.65 16.50 37416.71 2194.15 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 24.96 4.59 273.50 23.12 40.00
AMRUTAJAN HEALTH LTD 559.55 25.08 4.36 1617.69 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8671.45 113.25 24.83 21678.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 424.80 45.68 3.89 4493.92 118.35 437.40

COLINZ LABORATORIES LTD. shareholding pattern

Holding
33.99%
66.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

COLINZ LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
53.47 4.98 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 49.50
  • 26 Days 47.00
  • 10 Days 47.90
  • 50 Days 47.20
  • 12 Days 47.60
  • 100 Days 47.70
  • 20 Days 47.20
  • 200 Days 48.40
50.93 PIVOT
First Support 50.93 First Resistance 50.93 Second Support 50.93 Second Resistance 50.93 Third Support 50.93 Third Resistance 50.93
RSI 65.76 ADX 21.29 MACD 0.60 Williams % R 0.00 Commodity Channel Index (CCI) 176.27
Date 2026-05-29 Week 1078.00 Same Day 1814.00 Month 922.00
1 Year 0.19 3 Year 0.39
Over 1 Month
11.76% down
Over 1 Year
-14.77% down
Over 3 Months
18.13% down
Over 3 Years
11.09% down
Over 6 Months
34.34% down
Over 5 Years
29.96% down

COLINZ LABORATORIES LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Colinz Laboratories Ltd?

Answer Field

Colinz Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 53.47 as on May 29 2026 02:07 PM.

What is the Market Cap of Colinz Laboratories Ltd Share?

Answer Field

The market cap of Colinz Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 6.70 as on May 29 2026 02:07 PM.

What is the 52 Week High and Low of Colinz Laboratories Ltd?

Answer Field

The 52 Week High and Low of Colinz Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 87.91 and ₹ 36.11.

What is 1 year return for Colinz Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -14.77%.

What is the P/E Ratio of Colinz Laboratories Ltd Share?

Answer Field

As on May 29 2026 02:07 PM the price-to-earnings (PE) ratio for Colinz Laboratories Ltd share is 13.11.

What is the PB ratio of Colinz Laboratories Ltd Share?

Answer Field

As on May 29 2026 02:07 PM, the price-to-book (PB) ratio for Colinz Laboratories Ltd share is 69.70.

How to Buy Colinz Laboratories Ltd Share?

Answer Field

You can trade in Colinz Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Colinz Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Colinz Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Colinz Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|